Results 1 to 10 of about 57,775 (326)

Antinuclear antibodies in COVID 19 [PDF]

Clinical and Translational Science, 2021
We appreciated very much the interesting study by Chang et al. on the presence of antinuclear antibodies (ANAs) in patients with moderate/critical coronavirus disease 2019 (COVID 19). Both we and Chang and collaborators described the presence and significance of ANAs in patients with COVID‐19.
Paolo Muratori, Marco Lenzi, Luigi Muratori, Alessandro Granito   +3 more
doaj   +6 more sources

Can Antinuclear Antibodies (ANA) be Monoclonal? [PDF]

Case Reports in Nephrology, 2021
Background. Nuclear staining by immunofluorescence in a kidney biopsy is often seen in patients with positive antinuclear antibodies (ANA) in the serum. These ANA are usually polyclonal, but herein we report 9 cases with an unusual finding of monoclonal ...
Laura Biederman, Anjali A. Satoskar, Mohankumar Doraiswamy, Samir Parikh, Brad Rovin, Brian Mussio, Galina Mikhalina, Sergey V. Brodsky   +7 more
doaj   +2 more sources

A study of clinical manifestations and their association with antinuclear antibodies in various autoimmune connective tissue disorders

Indian Journal of Dermatology, 2023
Background: Autoimmune connective tissue diseases (AICTD) present with a myriad of clinical manifestations, including cutaneous. These disorders occur because of immune dysregulation that produces autoantibodies targeting connective tissue and internal ...
Rupa D Kondeti, K Venkatesh, D. V S. B Rama Murthy, Swapna Kameti, K Sri Devi, K V Chandrika   +5 more
doaj   +2 more sources

Association Between SARS-CoV-2 Vaccination and Development of Antinuclear Antibodies Among Students [PDF]

Journal of Primary Care & Community Health
Introduction: Antinuclear antibodies (ANA) are the hallmark of many connective tissue disorders (including lupus), which comprise roughly 5% to 10% of chronic debilitating diseases causing morbidity and mortality.
Karol Laskowski, Justyna Paszkiewicz, Dorota Plewik, Adam Szepeluk, Kamil K. Hozyasz   +4 more
doaj   +2 more sources

The Past, Present, and Future in Antinuclear Antibodies (ANA) [PDF]

Diagnostics, 2022
Autoantibodies are a hallmark of autoimmunity and, specifically, antinuclear antibodies (ANAs) are the most relevant autoantibodies present in systemic autoimmune rheumatic diseases (SARDs).
Juan Irure-Ventura, Marcos López-Hoyos
doaj   +2 more sources

Significance of antinuclear antibodies in patients with COVID-19 [PDF]

The Korean Journal of Internal Medicine, 2023
Oh-Hyun Cho
doaj   +2 more sources

Diagnostic and Clinical Value of Specific Autoantibodies against Kelch-like 12 Peptide and Nuclear Envelope Proteins in Patients with Primary Biliary Cholangitis

Biomedicines, 2022
Primary biliary cholangitis (PBC) is a chronic autoimmune liver disease characterized by the presence of antimitochondrial and antinuclear antibodies in patients’ serum.
Alicja Bauer, Andrzej Habior, Damian Gawel   +2 more
doaj   +1 more source

Antimitochindrial and antinuclear antibodies in primary biliary cholangitis [PDF]

Ķazaķstannyṇ Klinikalyķ Medicinasy, 2019
In this work we reviewed the key antimitochondrial and antinuclear antibodies in primary biliary cholangitis – an autoimmune cholestatic disorder with destruction of intralobular biliary ductules.
Dana Saipiyeva, Manarbek Askarov, Turlybek Tuganbekov, Kulsara Rustemova, Vladimir Grigorevsky, Gulmira Dossatayeva, Nina Tostanovskaya   +6 more
doaj   +1 more source

Complement Activation in Patients With Probable Systemic Lupus Erythematosus and Ability to Predict Progression to American College of Rheumatology-Classified Systemic Lupus Erythematosus. [PDF]

, 2020
ObjectiveTo evaluate the frequency of cell-bound complement activation products (CB-CAPs) as a marker of complement activation in patients with suspected systemic lupus erythematosus (SLE) and the usefulness of this biomarker as a predictor of the ...
Alexander, Roberta Vezza, Arriens, Cristina, Collins, Christopher E, Dervieux, Thierry, Kalunian, Kenneth C, Massarotti, Elena M, Narain, Sonali, O'Malley, Tyler, Putterman, Chaim, Ramsey-Goldman, Rosalind, Saxena, Amit, Wallace, Daniel J, Weinstein, Arthur   +12 more
core   +2 more sources

Antimelanocyte antibodies: A possible role in patients with vitiligo

Indian Journal of Dermatology, 2020
Background: Vitiligo is an acquired depigmenting skin disorder with multifactorial pathogenesis including genetic, autoimmune, and neuronal factors. Both humoral- and cell-mediated immunities are supposed to have a role in the pathogenesis of vitiligo ...
Maha A El-Gayyar, Manal E Helmy, Eman R Amer, Moustafa A Elsaied, Mohammad A Gaballah   +4 more
doaj   +1 more source